Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.
2.

Serial exposure to ethanol drinking and methamphetamine enhances glutamate excitotoxicity.

Blaker AL, Moore ER, Yamamoto BK.

J Neurochem. 2019 Sep 3. doi: 10.1111/jnc.14861. [Epub ahead of print]

PMID:
31478210
3.

Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism.

Blaker AL, Rodriguez EA, Yamamoto BK.

Brain Behav Immun. 2019 Oct;81:317-328. doi: 10.1016/j.bbi.2019.06.028. Epub 2019 Jun 20.

PMID:
31228610
4.

Cerebrovascular Injury After Serial Exposure to Chronic Stress and Abstinence from Methamphetamine Self-Administration.

Natarajan R, Mitchell CM, Harless N, Yamamoto BK.

Sci Rep. 2018 Jul 12;8(1):10558. doi: 10.1038/s41598-018-28970-1.

5.

Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin.

Edler MC, Salek AB, Watkins DS, Kaur H, Morris CW, Yamamoto BK, Baucum AJ 2nd.

ACS Chem Neurosci. 2018 Nov 21;9(11):2701-2712. doi: 10.1021/acschemneuro.8b00144. Epub 2018 Jun 1.

PMID:
29786422
6.

Methamphetamine-Induced Brain Injury and Alcohol Drinking.

Blaker AL, Yamamoto BK.

J Neuroimmune Pharmacol. 2018 Mar;13(1):53-63. doi: 10.1007/s11481-017-9764-3. Epub 2017 Aug 30.

7.

Chronic-Stress-Induced Behavioral Changes Associated with Subregion-Selective Serotonin Cell Death in the Dorsal Raphe.

Natarajan R, Forrester L, Chiaia NL, Yamamoto BK.

J Neurosci. 2017 Jun 28;37(26):6214-6223. doi: 10.1523/JNEUROSCI.3781-16.2017. Epub 2017 May 25.

8.

Disruption of the Glutamate-Glutamine Cycle Involving Astrocytes in an Animal Model of Depression for Males and Females.

Rappeneau V, Blaker A, Petro JR, Yamamoto BK, Shimamoto A.

Front Behav Neurosci. 2016 Dec 6;10:231. doi: 10.3389/fnbeh.2016.00231. eCollection 2016.

9.

MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

Huff CL, Morano RL, Herman JP, Yamamoto BK, Gudelsky GA.

Neurotoxicology. 2016 Dec;57:282-290. doi: 10.1016/j.neuro.2016.10.011. Epub 2016 Oct 20.

10.

Peripheral ammonia and blood brain barrier structure and function after methamphetamine.

Northrop NA, Halpin LE, Yamamoto BK.

Neuropharmacology. 2016 Aug;107:18-26. doi: 10.1016/j.neuropharm.2016.03.018. Epub 2016 Mar 10.

11.

3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling.

Collins SA, Huff C, Chiaia N, Gudelsky GA, Yamamoto BK.

J Neurochem. 2016 Mar;136(5):1074-84. doi: 10.1111/jnc.13493. Epub 2016 Jan 19.

12.

Protracted effects of chronic stress on serotonin-dependent thermoregulation.

Natarajan R, Northrop NA, Yamamoto BK.

Stress. 2015;18(6):668-76. doi: 10.3109/10253890.2015.1087502. Epub 2015 Sep 28.

13.

Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Stansley BJ, Yamamoto BK.

Psychopharmacology (Berl). 2015 Sep;232(17):3203-13. doi: 10.1007/s00213-015-3980-4. Epub 2015 Jun 3.

14.

Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.

Das SC, Yamamoto BK, Hristov AM, Sari Y.

Neuropharmacology. 2015 Oct;97:67-74. doi: 10.1016/j.neuropharm.2015.05.009. Epub 2015 May 19.

15.

MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors.

Collins SA, Gudelsky GA, Yamamoto BK.

Eur J Pharmacol. 2015 Aug 15;761:95-100. doi: 10.1016/j.ejphar.2015.04.035. Epub 2015 Apr 30.

16.

Methamphetamine effects on blood-brain barrier structure and function.

Northrop NA, Yamamoto BK.

Front Neurosci. 2015 Mar 4;9:69. doi: 10.3389/fnins.2015.00069. eCollection 2015. Review.

17.

L-Dopa and Brain Serotonin System Dysfunction.

Stansley BJ, Yamamoto BK.

Toxics. 2015 Mar 5;3(1):75-88. doi: 10.3390/toxics3010075. Review.

18.

Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.

Stansley BJ, Yamamoto BK.

J Pharmacol Exp Ther. 2014 Nov;351(2):440-7. doi: 10.1124/jpet.114.218966. Epub 2014 Sep 11.

19.

Effects of stress and MDMA on hippocampal gene expression.

Weber GF, Johnson BN, Yamamoto BK, Gudelsky GA.

Biomed Res Int. 2014;2014:141396. doi: 10.1155/2014/141396. Epub 2014 Jan 9.

20.

Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.

Halpin LE, Northrop NA, Yamamoto BK.

Neuropsychopharmacology. 2014 Mar;39(4):1031-8. doi: 10.1038/npp.2013.306. Epub 2013 Oct 29.

21.

Methamphetamine causes acute hyperthermia-dependent liver damage.

Halpin LE, Gunning WT, Yamamoto BK.

Pharmacol Res Perspect. 2013 Oct;1(1):e00008. doi: 10.1002/prp2.8. Epub 2013 Oct 1.

22.

Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Halpin LE, Collins SA, Yamamoto BK.

Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24. Review.

23.

Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.

Northrop NA, Yamamoto BK.

Neuropharmacology. 2013 Sep;72:96-105. doi: 10.1016/j.neuropharm.2013.04.040. Epub 2013 May 2.

24.

Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.

Huff C, Bhide N, Schroering A, Yamamoto BK, Gudelsky GA.

Brain Res Bull. 2013 Feb;91:52-7. doi: 10.1016/j.brainresbull.2013.01.003. Epub 2013 Jan 12.

25.

L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells.

Stansley BJ, Yamamoto BK.

Neuropharmacology. 2013 Apr;67:243-51. doi: 10.1016/j.neuropharm.2012.11.010. Epub 2012 Nov 27.

26.

MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA.

J Neuroimmune Pharmacol. 2013 Mar;8(1):58-65. doi: 10.1007/s11481-012-9420-x. Epub 2012 Nov 18.

27.

Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.

Peritore CS, Ho A, Yamamoto BK, Schaus SE.

Neuroreport. 2012 Dec 5;23(17):989-94. doi: 10.1097/WNR.0b013e32835a4ea4.

28.

Peripheral ammonia as a mediator of methamphetamine neurotoxicity.

Halpin LE, Yamamoto BK.

J Neurosci. 2012 Sep 19;32(38):13155-63.

29.

Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier.

Northrop NA, Yamamoto BK.

J Neuroimmune Pharmacol. 2012 Dec;7(4):951-68. doi: 10.1007/s11481-012-9391-y. Epub 2012 Jul 26.

30.

Methamphetamine-induced oxidation of proteins and alterations in protein processing.

Yamamoto BK, Yang FC.

Neuropsychopharmacology. 2012 Jan;37(1):298-9. doi: 10.1038/npp.2011.173. No abstract available.

31.

The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Natarajan R, Yamamoto BK.

Basal Ganglia. 2011 Jul 1;1(2):49-57.

32.

Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo.

Moszczynska A, Yamamoto BK.

J Neurochem. 2011 Mar;116(6):1005-17. doi: 10.1111/j.1471-4159.2010.07147.x. Epub 2011 Jan 19.

33.

Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.

Northrop NA, Smith LP, Yamamoto BK, Eyerman DJ.

J Pharmacol Exp Ther. 2011 Mar;336(3):900-7. doi: 10.1124/jpet.110.177287. Epub 2010 Dec 15.

34.

Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine.

McFadden L, Yamamoto BK, Matuszewich L.

Behav Brain Res. 2011 Jan 20;216(2):726-30. doi: 10.1016/j.bbr.2010.08.041. Epub 2010 Sep 9.

35.

Neuroimmune pharmacology from a neuroscience perspective.

Northrop NA, Yamamoto BK.

J Neuroimmune Pharmacol. 2011 Mar;6(1):10-9. doi: 10.1007/s11481-010-9239-2. Epub 2010 Aug 18. Review. Erratum in: J Neuroimmune Pharmacol. 2011 Mar;6(1):171. Northrup, Nicole A [corrected to Northrop, Nicole A].

36.

Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.

Johnson BN, Yamamoto BK.

J Pharmacol Exp Ther. 2010 Oct;335(1):180-9. doi: 10.1124/jpet.110.171322. Epub 2010 Jul 15.

37.

Amphetamine toxicities: classical and emerging mechanisms.

Yamamoto BK, Moszczynska A, Gudelsky GA.

Ann N Y Acad Sci. 2010 Feb;1187:101-21. doi: 10.1111/j.1749-6632.2009.05141.x. Review.

38.

Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine.

Doyle JR, Yamamoto BK.

Psychoneuroendocrinology. 2010 May;35(4):629-33. doi: 10.1016/j.psyneuen.2009.10.001. Epub 2009 Oct 29.

39.

MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.

Cunningham JI, Raudensky J, Tonkiss J, Yamamoto BK.

Behav Neurosci. 2009 Oct;123(5):1076-84. doi: 10.1037/a0016716.

40.

Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.

Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA.

Brain Res. 2009 Aug 25;1286:32-41. doi: 10.1016/j.brainres.2009.06.042. Epub 2009 Jun 23.

41.

Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.

Johnson BN, Yamamoto BK.

Neuroscience. 2009 Apr 10;159(4):1233-43. doi: 10.1016/j.neuroscience.2009.01.067. Epub 2009 Feb 3.

42.

The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Yamamoto BK, Raudensky J.

J Neuroimmune Pharmacol. 2008 Dec;3(4):203-17. doi: 10.1007/s11481-008-9121-7. Epub 2008 Aug 15. Review.

43.

Gender differences in zebrafish responses to cocaine withdrawal.

López Patiño MA, Yu L, Yamamoto BK, Zhdanova IV.

Physiol Behav. 2008 Sep 3;95(1-2):36-47. doi: 10.1016/j.physbeh.2008.03.021. Epub 2008 Apr 8.

44.
45.

Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Gudelsky GA, Yamamoto BK.

Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. Epub 2007 Oct 16. Review.

46.
47.

A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.

Eyerman DJ, Yamamoto BK.

J Neurochem. 2007 Nov;103(3):1219-27. Epub 2007 Aug 7.

48.
49.
50.

Supplemental Content

Loading ...
Support Center